DH
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer | Cellular and molecular life sciences | 2023 | 120 | 177 | |||
| CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells | Science Advances | 2023 | 78 | 148 | |||
| Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma | Journal of experimental & clinical cancer research | 2023 | 169 | 59 | |||
| Hsf1 and the molecular chaperone Hsp90 support a ‘rewiring stress response’ leading to an adaptive cell size increase in chronic stress | eLife | 2023 | 95 | 127 | |||
| Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer | Cancers | 2022 | 208 | 208 | |||
| Genetic and multidrug combinatorial screens unravel new mechanistic clues and optimised therapeutics for estrogen receptor alpha-mediated breast cancer | 2022 | 338 | 48 | ||||
| Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life | Nature communications | 2022 | 313 | 232 |
